Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Multiple Sclerosis and Related Disorders
|
April 27, 2020
Big pharma and social responsibility
Christopher H Hawkes, Gavin Giovannoni, Michael Levy, et al.
Multiple Sclerosis and Related Disorders
|
May 21, 2022
Onset of multiple sclerosis is preventable - time to act now!
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
August 13, 2025
Treatment of First and Subsequent Attacks in Multiple Sclerosis
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
January 25, 2023
Cancer risk and mortality in multiple sclerosis: The need for vigilance
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
October 15, 2024
FROM BENCH TO BEDSIDE: A SNAIL IN TREACLE?
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
June 4, 2023
Migraine and multiple sclerosis: The final answer?
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
January 22, 2026
Why don't all adults get multiple sclerosis?
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
July 8, 2022
EBV as the "gluten of MS" hypothesis provides a rationale for trialing antiviral therapies
Natalia Drosu, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
June 9, 2026
Raman spectroscopy and the Epstein Barr virus in multiple sclerosis
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
May 29, 2021
Melatonin and multiple sclerosis
Christopher H Hawkes, Mark D Baker, Daniela Pohl, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Multiple Sclerosis and Related Disorders
|
April 27, 2020
Big pharma and social responsibility
Christopher H Hawkes, Gavin Giovannoni, Michael Levy, et al.
Multiple Sclerosis and Related Disorders
|
May 21, 2022
Onset of multiple sclerosis is preventable - time to act now!
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
August 13, 2025
Treatment of First and Subsequent Attacks in Multiple Sclerosis
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
January 25, 2023
Cancer risk and mortality in multiple sclerosis: The need for vigilance
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
October 15, 2024
FROM BENCH TO BEDSIDE: A SNAIL IN TREACLE?
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
June 4, 2023
Migraine and multiple sclerosis: The final answer?
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
January 22, 2026
Why don't all adults get multiple sclerosis?
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
July 8, 2022
EBV as the "gluten of MS" hypothesis provides a rationale for trialing antiviral therapies
Natalia Drosu, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
June 9, 2026
Raman spectroscopy and the Epstein Barr virus in multiple sclerosis
Christopher H Hawkes, Gavin Giovannoni, Jeanette Lechner-Scott, et al.
Multiple Sclerosis and Related Disorders
|
May 29, 2021
Melatonin and multiple sclerosis
Christopher H Hawkes, Mark D Baker, Daniela Pohl, et al.
Page
of 5